RETROPERITONEAL SARCOMA
Clinical trials for RETROPERITONEAL SARCOMA explained in plain language.
Never miss a new study
Get alerted when new RETROPERITONEAL SARCOMA trials appear
Sign up with your email to follow new studies for RETROPERITONEAL SARCOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New radiation combo aims to shrink tumors before surgery for rare cancer
Disease control Recruiting nowThis study is testing a new way of giving radiation before surgery for a rare type of cancer called retroperitoneal sarcoma. The goal is to see if this approach is safe and reduces complications during and after surgery. About 50 adults with this cancer will receive focused radia…
Matched conditions: RETROPERITONEAL SARCOMA
Phase: NA • Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences • Aim: Disease control
Last updated May 17, 2026 06:59 UTC
-
Promising combo targets rare sarcoma before surgery
Disease control Recruiting nowThis early-phase trial tests the safety and best dose of the drug abemaciclib when given with radiation therapy before surgery for a rare, high-risk type of abdominal cancer called retroperitoneal sarcoma. The study enrolls 18 adults whose tumors have certain genetic markers. The…
Matched conditions: RETROPERITONEAL SARCOMA
Phase: PHASE1 • Sponsor: University of Washington • Aim: Disease control
Last updated May 17, 2026 06:47 UTC
-
New radiation approach aims to shrink deep tumors before surgery
Disease control Recruiting nowThis study tests a new way to give radiation before surgery for retroperitoneal sarcoma, a rare tumor deep in the abdomen. About 80 adults will receive either proton or photon radiation, with a higher dose to high-risk areas of the tumor. The goal is to find the safest highest do…
Matched conditions: RETROPERITONEAL SARCOMA
Phase: PHASE1, PHASE2 • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated May 15, 2026 11:56 UTC
-
Could chemo before surgery beat sarcoma? new trial seeks answers
Disease control Recruiting nowThis study tests whether giving chemotherapy before surgery helps people with high-risk retroperitoneal sarcoma (a rare cancer in the abdomen) live longer without the cancer coming back. About 250 adults with specific sarcoma types will be randomly assigned to receive chemo then …
Matched conditions: RETROPERITONEAL SARCOMA
Phase: PHASE3 • Sponsor: European Organisation for Research and Treatment of Cancer - EORTC • Aim: Disease control
Last updated May 15, 2026 11:53 UTC
-
New proton beam technique targets Hard-to-Treat sarcomas
Disease control Recruiting nowThis study tests a new type of proton radiation called P-SFRT, given alongside standard radiation, for people with a rare cancer called retroperitoneal sarcoma. The goal is to find the safest dose and see if it helps shrink tumors before surgery. About 28 adults with newly diagno…
Matched conditions: RETROPERITONEAL SARCOMA
Phase: PHASE1, PHASE2 • Sponsor: Northwestern University • Aim: Disease control
Last updated May 14, 2026 12:06 UTC
-
Electric shocks and chemo: new hope for inoperable tumors?
Disease control Recruiting nowThis study tests a treatment called electrochemotherapy for people with tumors in organs like the liver or pancreas that cannot be removed with surgery. The treatment uses short electric pulses to help chemotherapy drugs enter cancer cells more effectively. The goal is to see if …
Matched conditions: RETROPERITONEAL SARCOMA
Phase: NA • Sponsor: Istituto Oncologico Veneto IRCCS • Aim: Disease control
Last updated May 11, 2026 20:39 UTC
-
New radiation approach aims to cut treatment time for rare sarcoma
Symptom relief Recruiting nowThis early-phase trial tests a shorter, more intense radiation schedule for people with retroperitoneal sarcoma, a rare cancer in the abdomen. The main goal is to see if this approach is safe by tracking side effects like nausea and diarrhea within 30 days. Only 6 participants wi…
Matched conditions: RETROPERITONEAL SARCOMA
Phase: PHASE1 • Sponsor: Brigham and Women's Hospital • Aim: Symptom relief
Last updated May 17, 2026 07:01 UTC
-
Sarcoma atlas aims to tailor chemo for 800 patients
Knowledge-focused Recruiting nowThis study looks at tissue and imaging data from 800 people with high-risk soft tissue sarcoma to find ways to personalize chemotherapy. Participants either have surgery alone or chemo before surgery. The goal is to build a tumor atlas and a tool to predict who benefits from chem…
Matched conditions: RETROPERITONEAL SARCOMA
Sponsor: Royal Marsden NHS Foundation Trust • Aim: Knowledge-focused
Last updated May 17, 2026 06:51 UTC
-
New study aims to improve surgery decisions for rare sarcoma patients
Knowledge-focused Recruiting nowThis study looks at different surgical methods for removing colorectal parts during treatment for retroperitoneal sarcoma, a rare cancer in the abdomen. Researchers will track complications and use surveys to measure patients' quality of life after surgery. The goal is to help su…
Matched conditions: RETROPERITONEAL SARCOMA
Sponsor: Heidelberg University • Aim: Knowledge-focused
Last updated May 17, 2026 06:48 UTC